Dr. Steve Harr serves as the President and Chief Executive Officer of Sana Biotechnology, guiding the enterprise since its co-founding. With an extensive professional background spanning executive management roles at leading biopharmaceutical firms and former leadership experience as a managing director and head of biotechnology investment banking at major financial institutions, he oversees the company's strategic focus on engineered cell and gene therapies.